Elevation Oncology, Inc. (ELEV)

Exchange NASDAQ
1.5


Currency in USD (Disclaimer)
Volume:
Day's Range:

ELEV Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-17 Hu Lori director 15,619.0 A-Award A 15,619.0 1.31 20,460.89
2022-06-17 Walsh Colin director 15,619.0 A-Award A 15,619.0 1.31 20,460.89
2022-06-17 Aisling Capital IV, LP 10 percent owner 15,619.0 A-Award A 15,619.0 1.31 20,460.89
2022-06-17 Carruthers R Michael director 15,619.0 A-Award A 15,619.0 1.31 20,460.89
2022-06-17 CLACKSON TIMOTHY P director 15,619.0 A-Award A 15,619.0 1.31 20,460.89
2022-05-31 CLACKSON TIMOTHY P director 15,777.0 G-Gift D 31,553.0 0.00 0.00
2022-05-25 venBio Global Strategic Fund III, L.P. 10 percent owner 1,905,430.0 S-Sale D 702,737.0 4.12 2,897,806.29
2022-03-14 Dornan David officer: Chief Scientific Officer 230,000.0 A-Award A 230,000.0 2.65 609,500.00
2022-02-14 Jansen Valerie Malyvanh officer: Chief Medical Officer 60,000.0 A-Award A 60,000.0 3.78 226,800.00
2022-02-14 Ferra Joseph J Jr officer: Chief Financial Officer 60,000.0 A-Award A 60,000.0 3.78 226,800.00
2022-02-14 Leland Shawn director, officer: President, CEO 186,500.0 A-Award A 186,500.0 3.78 704,970.00
2021-10-19 Jansen Valerie Malyvanh officer: Chief Medical Officer 40,000.0 A-Award A 40,000.0 7.58 303,200.00
2021-06-29 Vertex Global HC Fund II Pte. Ltd. 10 percent owner 0.0 C-Conversion D 1,694,730.0 0.00 0.00
2021-06-29 Vertex Global HC Fund II Pte. Ltd. 10 percent owner 0.0 C-Conversion D 1,694,730.0 0.00 0.00
2021-06-29 Vertex Global HC Fund II Pte. Ltd. 10 percent owner 2,307,642.0 P-Purchase A 250,000.0 16.00 4,000,000.00
2021-06-29 Vertex Global HC Fund II Pte. Ltd. 10 percent owner 2,057,642.0 C-Conversion A 401,065.0 0.00 0.00
2021-06-29 Vertex Global HC Fund II Pte. Ltd. 10 percent owner 1,656,577.0 C-Conversion A 1,656,577.0 0.00 0.00
2021-06-29 Aisling Capital IV, LP 10 percent owner 0.0 C-Conversion D 1,936,834.0 0.00 0.00
2021-06-29 Aisling Capital IV, LP 10 percent owner 0.0 C-Conversion D 1,936,834.0 0.00 0.00
2021-06-29 Aisling Capital IV, LP 10 percent owner 2,834,910.0 P-Purchase A 187,500.0 16.00 3,000,000.00
2021-06-29 Aisling Capital IV, LP 10 percent owner 2,647,410.0 C-Conversion A 458,360.0 0.00 0.00
2021-06-29 Aisling Capital IV, LP 10 percent owner 2,189,050.0 C-Conversion A 1,893,232.0 0.00 0.00
2021-06-29 Qiming U.S. Healthcare Fund II, L.P. 10 percent owner 0.0 C-Conversion D 1,694,730.0 0.00 0.00
2021-06-29 Qiming U.S. Healthcare Fund II, L.P. 10 percent owner 0.0 C-Conversion D 1,694,730.0 0.00 0.00
2021-06-29 Qiming U.S. Healthcare Fund II, L.P. 10 percent owner 2,370,142.0 P-Purchase A 312,500.0 16.00 5,000,000.00
2021-06-29 Qiming U.S. Healthcare Fund II, L.P. 10 percent owner 2,057,642.0 C-Conversion A 401,065.0 0.00 0.00
2021-06-29 Cormorant Asset Management, LP other: Former 10% Owner 0.0 C-Conversion D 1,983,168.0 0.00 0.00
2021-06-29 venBio Global Strategic Fund III, L.P. 10 percent owner 1,983,167.0 C-Conversion A 1,983,167.0 0.00 0.00
2021-06-29 venBio Global Strategic Fund III, L.P. 10 percent owner 0.0 C-Conversion D 8,380,034.0 0.00 0.00
2021-06-29 venBio Global Strategic Fund III, L.P. 10 percent owner 2,608,167.0 P-Purchase A 625,000.0 16.00 10,000,000.00
2021-06-29 Cormorant Asset Management, LP other: Former 10% Owner 1,983,168.0 C-Conversion A 1,983,168.0 0.00 0.00
2021-06-29 Cormorant Asset Management, LP other: Former 10% Owner 2,233,168.0 P-Purchase A 250,000.0 16.00 4,000,000.00
2021-06-29 Qiming U.S. Healthcare Fund II, L.P. 10 percent owner 1,656,577.0 C-Conversion A 1,656,577.0 0.00 0.00
2021-06-24 Aisling Capital IV, LP 10 percent owner 31,238.0 A-Award A 31,238.0 16.00 499,808.00
2021-06-24 Walsh Colin director 31,238.0 A-Award A 31,238.0 16.00 499,808.00
2021-06-24 Ferra Joseph J Jr officer: Chief Financial Officer 200,995.0 A-Award A 200,995.0 0.00 0.00
2021-06-24 Ferra Joseph J Jr officer: Chief Financial Officer 249,104.0 A-Award A 249,104.0 16.00 3,985,664.00
2021-06-24 Hu Lori director 31,238.0 A-Award A 31,238.0 16.00 499,808.00
2021-06-24 Gaster Richard director 31,238.0 A-Award A 31,238.0 16.00 499,808.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.